tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market
Holding CDT?
Track your performance easily

Conduit Pharmaceuticals (CDT) Stock Price & Analysis

169 Followers

CDT Stock Chart & Stats


Financials

Annual

Ownership Overview

9.75%0.79%0.08%88.73%
0.08% Other Institutional Investors
88.73% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

CDT FAQ

What was Conduit Pharmaceuticals’s price range in the past 12 months?
Conduit Pharmaceuticals lowest stock price was $0.08 and its highest was $7.83 in the past 12 months.
    What is Conduit Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Conduit Pharmaceuticals’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Conduit Pharmaceuticals’s earnings last quarter?
    Currently, no data Available
    Is Conduit Pharmaceuticals overvalued?
    According to Wall Street analysts Conduit Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Conduit Pharmaceuticals pay dividends?
      Conduit Pharmaceuticals does not currently pay dividends.
      What is Conduit Pharmaceuticals’s EPS estimate?
      Conduit Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Conduit Pharmaceuticals have?
      Conduit Pharmaceuticals has 102,847,980 shares outstanding.
        What happened to Conduit Pharmaceuticals’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Conduit Pharmaceuticals?
        Among the largest hedge funds holding Conduit Pharmaceuticals’s share is Saba Capital Management. It holds Conduit Pharmaceuticals’s shares valued at N/A.
          ---

          Company Description

          Conduit Pharmaceuticals

          Murphy Canyon Acquisition Corp is a blank check company.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Corbus Pharmaceuticals
          Ovid Therapeutics
          Aurinia Pharmaceuticals
          Bioxcel Therapeutics
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis